|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
6
|
Resverlogix Corp.
|
Sep 25, 2018 12:48PM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
5
|
Resverlogix Corp.
|
Sep 25, 2018 03:44PM
|
|
Updates on ClinicalTrials.gov
|
5
|
Resverlogix Corp.
|
Sep 26, 2018 02:44PM
|
|
"Getting cancer drugs into the brain" article in Nature Outlooks mentions BiOasis
|
4
|
BIOASIS TECHNOLOGIES INC
|
Sep 27, 2018 09:54AM
|
|
Re: Resverlogix H2 2018 events
|
2
|
Resverlogix Corp.
|
Sep 27, 2018 03:46PM
|
|
Re: Resverlogix H2 2018 events
|
6
|
Resverlogix Corp.
|
Sep 29, 2018 01:21PM
|
|
Re: Resverlogix H2 2018 events
|
4
|
Resverlogix Corp.
|
Sep 29, 2018 02:03PM
|
|
Re: Resverlogix H2 2018 events
|
5
|
Resverlogix Corp.
|
Sep 29, 2018 05:18PM
|
|
Zenith Epigenetics Announces Publication of Covalent Bromodomain Inhibitors, Offering a Novel Approach to Targeting BET Bromodomains
|
6
|
Zenith Epigenetics
|
Oct 01, 2018 09:43AM
|
|
Re: Zenith Epigenetics Announces Publication of Covalent Bromodomain Inhibitors, Offering a Novel Approach to Targeting BET Bromodomains
|
5
|
Zenith Epigenetics
|
Oct 01, 2018 09:57AM
|
|
CVOTs on the Horizon
|
3
|
Resverlogix Corp.
|
Oct 01, 2018 04:04PM
|
|
Re: CVOTs on the Horizon
|
2
|
Resverlogix Corp.
|
Oct 01, 2018 04:22PM
|
|
Re: CVOTs on the Horizon
|
6
|
Resverlogix Corp.
|
Oct 01, 2018 05:48PM
|
|
Re: "Getting cancer drugs into the brain" article in Nature Outlooks mentions BiOasis
|
5
|
BIOASIS TECHNOLOGIES INC
|
Oct 01, 2018 10:20PM
|
|
Re: CVOTs on the Horizon
|
2
|
Resverlogix Corp.
|
Oct 02, 2018 10:02AM
|
|
Re: Zenith Epigenetics Announces Publication of Covalent Bromodomain Inhibitors, Offering a Novel Approach to Targeting BET Bromodomains
|
4
|
Zenith Epigenetics
|
Oct 02, 2018 10:27AM
|
|
Re: CVOTs on the Horizon
|
3
|
Resverlogix Corp.
|
Oct 02, 2018 10:48AM
|
|
Re: What are the biggest hints that BETonMACE will be a huge success,..
|
3
|
Resverlogix Corp.
|
Oct 02, 2018 01:12PM
|
|
Re: What are the biggest hints that BETonMACE will be a huge success,..
|
2
|
Resverlogix Corp.
|
Oct 02, 2018 02:17PM
|
|
Re: FXR and liver transaminase related adverse events
|
5
|
Resverlogix Corp.
|
Oct 03, 2018 11:32AM
|
